Chemistry, part 1

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > ureas > n(2)-(morpholin-4-ylcarbonyl)-n(1)-[(1s,2e)-1-(2-phenylethyl)-3-(phenylsulfonyl)prop-2-enyl]-d-leucinamide

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > oxazinane > morpholines > n(2)-(morpholin-4-ylcarbonyl)-n(1)-[(1s,2e)-1-(2-phenylethyl)-3-(phenylsulfonyl)prop-2-enyl]-d-leucinamide

organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > n(2)-(morpholin-4-ylcarbonyl)-n(1)-[(1s,2e)-1-(2-phenylethyl)-3-(phenylsulfonyl)prop-2-enyl]-d-leucinamide

organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > n(2)-(morpholin-4-ylcarbonyl)-n(1)-[(1s,2e)-1-(2-phenylethyl)-3-(phenylsulfonyl)prop-2-enyl]-d-leucinamide

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > amino-acid derivative > non-proteinogenic amino acid derivative > d-leucine derivative > n(2)-(morpholin-4-ylcarbonyl)-n(1)-[(1s,2e)-1-(2-phenylethyl)-3-(phenylsulfonyl)prop-2-enyl]-d-leucinamide

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > amino-acid derivative > leucine derivative > d-leucine derivative > n(2)-(morpholin-4-ylcarbonyl)-n(1)-[(1s,2e)-1-(2-phenylethyl)-3-(phenylsulfonyl)prop-2-enyl]-d-leucinamide